Albiglutide
Composition
Contains Albiglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist.
Indications
Used to improve glycemic control in adults with type 2 diabetes mellitus.
Side effects
Nausea, diarrhea, injection site reactions, headache, potential risk of pancreatitis.
Precautions
Monitor for signs of pancreatitis; caution in patients with thyroid cancer history; avoid in type 1 diabetes.
Contraindications
Personal or family history of medullary thyroid carcinoma or MEN 2; hypersensitivity to albiglutide.
Dosage and administration
Administered as a once-weekly subcutaneous injection, usually 30 mg, may increase to 50 mg.
Countries
Available Forms
Pre-filled injection pens for subcutaneous use.